Patrick Monteverde In play, run(s) to Aaron Schunk

Promega BlogPromega Builds Opportunity to Appreciate Hidden Wetland

FierceBiotechADA: Novo’s Lange says ‘jury still out’ on CagriSema amid tough retatrutide comparisons

BioPharma DiveEthyreal starts up with $101M and takes aim at a pair of immune diseases

Clinical OMICsEngineered Salmonella Delivers Cancer-Killing Virus to Tumors

Endpoints NewsNovartis and Orionis strike second molecular glue deal for $40M upfront

FierceBiotechGLP-1s may combat depression by multiplying a mood-boosting gut microbe

BioPharma DiveSanofi stops immune drug trial in latest research setback

Endpoints NewsSonoThera raises $125M for non-viral gene therapy approach

BioPharma DiveParabilis sets a record with a $670M biotech IPO

FierceBiotechBig Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery

Clinical OMICsGLP-1s May Benefit Mental Health Through Gut–Brain Axis

Clinical OMICsPhase Ib/IIa for Hepatitis B Epigenetic Silencer Shows Best-in-Class Potential